DBF-30993-72380 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-29
Registered in v-safe
2021-01-29
Dose 1 — Pfizer-BioNTech
2021-01-29
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-02-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-02
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-14
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-02-20
Dose 2 — Pfizer-BioNTech
2021-02-20
Survey response — day 0, dose 2
MedDRA: Epistaxis — Feeling: Good · Site: Pain

Free text: Nose bleeding

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-21
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-02-22
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-24
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-12-22
Dose 3 — Pfizer-BioNTech
2022-06-27
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-29	Pfizer-BioNTech
2	2021-02-20	Pfizer-BioNTech
3	2021-12-22	Pfizer-BioNTech	No

Free text

Release 4 — day 0, dose 2

2021-02-20

Systemic reaction (other): Nose bleeding

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Epistaxis	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release